title: Complementary and alternative medicine use in oncology: a questionnaire survey of patients and health care professionals.
abstract: BACKGROUND
  We aimed to investigate the prevalence and predictors of Complementary and Alternative Medicine (CAM) use among cancer patients and non-cancer volunteers, and to assess the knowledge of and attitudes toward CAM use in oncology among health care professionals.
  
  
  METHODS
  This is a cross-sectional questionnaire survey conducted in a single institution in Ireland. Survey was performed in outpatient and inpatient settings involving cancer patients and non-cancer volunteers. Clinicians and allied health care professionals were asked to complete a different questionnaire.
  
  
  RESULTS
  In 676 participants including 219 cancer patients; 301 non-cancer volunteers and 156 health care professionals, the overall prevalence of CAM use was 32.5% (29.1%, 30.9% and 39.7% respectively in the three study cohorts). Female gender (p < 0.001), younger age (p = 0.004), higher educational background (p < 0.001), higher annual household income (p = 0.001), private health insurance (p = 0.001) and non-Christian (p < 0.001) were factors associated with more likely CAM use. Multivariate analysis identified female gender (p < 0.001), non-Christian (p = 0.001) and private health insurance (p = 0.015) as independent predictors of CAM use. Most health care professionals thought they did not have adequate knowledge (58.8%) nor were up to date with the best evidence (79.2%) on CAM use in oncology. Health care professionals who used CAM were more likely to recommend it to patients (p < 0.001).
  
  
  CONCLUSIONS
  This study demonstrates a similarly high prevalence of CAM use among oncology health care professionals, cancer and non cancer patients. Patients are more likely to disclose CAM usage if they are specifically asked. Health care professionals are interested to learn more about various CAM therapies and have poor evidence-based knowledge on specific oncology treatments. There is a need for further training to meet to the escalation of CAM use among patients and to raise awareness of potential benefits and risks associated with these therapies.
authors: Department of Surgery, University College Hospital Galway, National University of Ireland.
authors: Kah Hoong
authors: KH
authors: Chang
authors: Rachel
authors: R
authors: Brodie
authors: Mei Ann
authors: MA
authors: Choong
authors: Karl J
authors: KJ
authors: Sweeney
authors: Michael J
authors: MJ
authors: Kerin
references: Support Care Cancer. 1999 Nov;7(6):396-9
references: 10541981
references: Med J Aust. 1996 Nov 18;165(10):545-8
references: 8941239
references: Eur J Cancer. 2000 Jul;36(11):1359-64
references: 10899648
references: Eur J Cancer. 1995 Oct;31A(11):1785-9
references: 8541101
references: N Engl J Med. 1993 Jan 28;328(4):246-52
references: 8418405
references: Ann Oncol. 2009 Apr;20(4):752-7
references: 19150956
references: Cochrane Database Syst Rev. 2005 Jan 25;(1):CD004540
references: 15674951
references: J Natl Cancer Inst. 2002 Aug 21;94(16):1247-9
references: 12189228
references: J Clin Oncol. 1998 Nov;16(11):3649-55
references: 9817287
references: Cochrane Database Syst Rev. 2003;(2):CD002141
references: 12804424
references: Br J Anaesth. 2000 Mar;84(3):367-71
references: 10793599
references: Ann Oncol. 2005 Apr;16(4):655-63
references: 15699021
references: BMC Complement Altern Med. 2009 May 14;9:14
references: 19442268
references: Complement Ther Med. 2004 Jun-Sep;12(2-3):90-8
references: 15561518
references: Lancet. 1996 Mar 2;347(9001):569-73
references: 8596318
references: J Altern Complement Med. 2009 Jan;15(1):35-40
references: 19769474
references: Support Care Cancer. 2004 Nov;12(11):797-804
references: 15378417
references: Arch Gynecol Obstet. 1996;258(2):81-8
references: 8779615
references: JAMA. 1998 Nov 11;280(18):1569-75
references: 9820257
references: Complement Ther Med. 2010 Apr;18(2):95-103
references: 20430292
references: J Clin Oncol. 2001 May 1;19(9):2439-48
references: 11331323
references: Ann Oncol. 2008 Jan;19(1):49-55
references: 17965113
references: BMJ. 1994 Jul 9;309(6947):107-11
references: 8038643
references: J Clin Oncol. 2007 Feb 10;25(5):548-54
references: 17290064
references: Eur Arch Otorhinolaryngol. 2010 Aug;267(8):1291-7
references: 20229270
references: J Clin Oncol. 2005 Apr 20;23(12):2645-54
references: 15728227
references: Cochrane Database Syst Rev. 2007 Jan 24;(1):CD004597
references: 17253515
references: Cancer. 2003 Jun 1;97(11):2861-8
references: 12767101
references: Cancer. 2008 Sep 1;113(5):1048-57
references: 18680170
references: Cancer. 2005 Jul 1;104(1):176-82
references: 15912493
references: Eur J Cancer Care (Engl). 2009 May;18(3):271-9
references: 19432919
references: J Clin Oncol. 2000 Jul;18(13):2505-14
references: 10893280
references: Eur J Cancer. 2004 Mar;40(4):529-35
references: 14962719
references: BMJ. 2001 Jan 20;322(7279):154-8
references: 11159576
references: J Clin Oncol. 2005 Oct 1;23(28):7188-98
references: 16192603
references: Cancer. 2000 Aug 15;89(4):873-80
references: 10951352